期刊文献+

亚甲基四氢叶酸还原酶基因A1298C多态性与帕金森病易感性的Meta分析

Meta-analysis on methlenetetrahydrofolate reductase gene polymorphisms and Parkinson's disease susceptibility
下载PDF
导出
摘要 目的探讨亚甲基四氢叶酸还原酶(MTHFR)基因A1298C位点单核苷酸多态性(SNP)与帕金森病(PD)易感性的关联情况。方法通过中国生物医学文献数据库、中国期刊网全文数据库、万方数据库、维普信息资源系统,PubMed、CochraneLibrary、〇vidSP、WileyOnlineLibrary、SpringerLink、EBSCO、ElevierScienceDictGooglescholar数据库检索MTHFR基因A1298C位点SNP与PD相关的病例对照研究,利用RevMan5.3和Stata12.0软件,根据异质性大小选用随机效应或固定效应模型对各研究数据进行分析。结果共纳入8篇文献。蚧^1分析结果提示卩0组和对照组人人基因型[0没=0.92,95%?/:0.78~1.09,/3=0.33]和〔〔基因型[0没=1.19,95%?/:0.89~1.59,/3=0.23]、人等位基因[0没=0.92,95%?/:0.81~1.04,/3=0.19]和〔等位基因[〇穴=1.09,95%a:0.96~1.24,P=0.19]差异均无统计学意义。 Objective To explore the association between A1298C polymorphism of methlenetetrahydrofolatereductase (MTHFR) gene and Parkinsons disease (PD) susceptibility. Methods The case-control studies of MTHFRgene and PD were selected from Chinese Biomedical Database, Chinese National Knowledge Infrastructure, Wanfang,Weipu,PubMed, Cochrane Library, OvidSP, Wiley Online Library, EBSCO, Elsevier Science Direct, Springer Link andGoogle scholar databases. The study data were analysed by random - effects or fixed - effects models depending on heter-ogeneity use RevMan 5. 3 and Stata 12. 0 software. Results Eight articles were included. The meta - analysis resultssuggested that there were no significant differences in genotype AA[ OR =0.92,95% Cl: 0. 78 - 1.09 = 0. 33 ] ,geno-type CC[ OR = 1.19,95% Cl: 0.89 - 1.59,P= 0.23] ,allele A[OR = 0.92,95% Cl : 0.81 - 1.04,P =0.19] and al-lele C [ OR = 1.09,95% Cl: 0. 96 - 1.24 = 0. 19 ] between PD group and control group. Conclusion No relationshipis found between the A1298C polymorphism of MTHFR gene and PD susceptibility.
作者 王璇 严光 孙梦雯 刘晓敏 Wang Xuan;Yan Guang;Sun Mengqwen;Liu Xiamin(Department of Geriatrics, the Affiliated Provincial Hospital of Anhui Medical University,Hefei 230001,China)
出处 《中国临床保健杂志》 CAS 2016年第2期197-201,共5页 Chinese Journal of Clinical Healthcare
基金 安徽省国际科技合作计划(11030603025)
关键词 帕金森病 亚甲基四氢叶酸还原酶(NADPH) 多态性 单核苷酸 Mea分析 Parkinson s disease Methylenetetrahydrofolate reductase ( NADPH2 ) Polymorphism, single nucleotide Meta analysis
  • 相关文献

参考文献24

  • 1Searles Nielsen S,Bammler TK,Gallagher LG,et al. Genotype and age at Parkinson disease diagnosis [ J ]. Int J Mol Epidemiol Genet,2013 ,4( 1) : 61-69.
  • 2杨猛,邝晓聪,潘延斌,谭美乐,卢斌珠,程秋梅,庞国栋,吴玲艳,李建民.XPD Lys751Gln核苷酸多态性与皮肤黑色素瘤易感性关系的Meta分析[J].实用医学杂志,2013,29(19):3237-3240. 被引量:1
  • 3Momose Y, Murata M, Kobayashi K, et al. Association studies of multiple candidate genes for Parkinsons disease using single nucleotide polymorphisms [ J ]. Ann Neurol, 2002,51(1) : 133-136.
  • 4Wtillner U,Kolsch H,Linnebank M. Methylenetetrahydro- folate reductase in Parkinson^s disease [J]. Ann Neurol, 2005,58(6) : 972-973.
  • 5Caccamo D,Gorgone G,Curro M,et al. Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa- treated Parkinsonian patients [ J ]. Neuromolecular Med, 2007,9(3) : 249-254.
  • 6Dorszewska J, Florczak J, Rozycka A, et al. Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer's and Parkinson's diseases [J]. Acta Neurobiol Exp (Wars), 2007,67(2) : 113-129.
  • 7Camicioli RM,Bouchard TP,Somerville MJ. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients [ J ]. Mov Disord,2009,24(2) : 176-182.
  • 8Yuan RY,Sheu JJ,Yu JM,et al. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease pa- tients[J]. J Neurol Sci ,2009,287( 1-2) : 64-68.
  • 9Rodriguez-Oroz MC,Lage PM, Sanchez-Mut J,et al. Ho-mocysteine and cognitive impairment in Parkinson^s disease :a biochemical,neuroimaging,and genetic study[J]. Mov Disord,2009,24(10) : 1437-1444.
  • 10Biaiecka M,Kurzawski M,Roszmann A,et al. Association of COMT,MTHFR,and SLC19A1 ( RFC-1 ) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson^s disease [ J ]. Pharmacogenet Ge- nomics,2012,22(10) : 716-724.

二级参考文献13

  • 1Gershenwald J E, Giacco G G, Lee J E. Cutaneous Melanoma [M]// 60 Years of survival outcomes at The University of Texas MD Anderson Cancer Center. Springer, 2013:153-165.
  • 2Alberg A J, Jorgensen T J, Ruczinski I, et al. DNA repair gene variants in relation to overall cancer risk: a population- based study [J]. Carcinogenesis, 2013, 34(1): 86-92.
  • 3Wlodarczyk M, Nowicka G. XPD gene rs13181 polymorphism and DNA damage in human lymphocytes [J]. Biochem Genet, 2012, 50(11-12): 860-870.
  • 4Winsey S L, Haldar N A, Marsh H P, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer [J]. Cancer Res, 2000, 60(20) : 5612-5616.
  • 5Baccarelli A, Calista D, Minghetti P, et al. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk [J]. Br J Cancer, 2004, 90(2) : 497-502.
  • 6Han J, Colditz G A, Liu J S, et al. Genetic variation in XPD, sun exposure, and risk of skin cancer [J]. Cancer Epidemiol Biomarkers Prey, 2005, 14(6): 1539-1544.
  • 7Debniak T, Scott R J, Huzarski T, et al. XPD common variants and their association with melanoma and breast cancer risk [Jl. Breast Cancer Res Treat, 2006, 98(2): 209-215.
  • 8Li C, Hu Z, Liu Z, et al. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis [J]. Cancer Epidemiol Biomarkers Prey, 2006, 15(12): 2526-2532.
  • 9Millikan R C, Hummer A, Begg C, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study [J]. Carcinogenesis, 2006, 27(3): 610-618.
  • 10Povey J E, Darakhshan F, Robertson K, et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma [J]. Carcinogenesis, 2007, 28(5) : 1087-1093.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部